| 1. |
- Ahlberg, Mats Steinholtz, et al.
(author)
-
PCASTt/SPCG-17-A randomised trial of active surveillance in prostate cancer: Rationale and design
- 2019
-
In: BMJ Open. - : BMJ. - 2044-6055. ; 9
-
Journal article (peer-reviewed)abstract
- Introduction Overtreatment of localised prostate cancer is substantial despite increased use of active surveillance. No randomised trials help define how to monitor patients or when to initiate treatment with curative intent. Methods and analysis A randomised, multicentre, intervention trial designed to evaluate the safety of an MRI-based active surveillance protocol, with standardised triggers for repeated biopsies and radical treatment. The aim is to reduce overtreatment of prostate cancer. 2000 men will be randomly allocated to either surveillance according to current practice or to standardised triggers at centres in Sweden, Norway, Finland and the UK. Men diagnosed in the past 12 months with prostate cancer, ≤T2a, prostate-specific antigen (PSA) <15 ng/mL, PSA density ≤0.2 ng/mL/cc, any International Society of Urological Pathology (ISUP) grade 1 are eligible. Men with ISUP grade 2 in <30% of cores on systematic biopsy and <10 mm cancer in one core on systematic or targeted biopsy are also eligible. Men diagnosed on systematic biopsy should have an MRI and targeted biopsies against Prostate Imaging and Reporting Data System V.2 3-5 lesions before inclusion. Identical follow-up in the two study arms: biannual PSA testing, yearly clinical examination and MRI every second year. In the experimental arm, standardised triggers based on MRI and PSA density elicit repeated biopsies. MRI and histopathological progression trigger radical treatment. Primary outcome measure is progression-free survival. Secondary outcome measures are cumulative incidence of metastatic disease, treatments with curative intent, pT3-4 at radical prostatectomy, switch to watchful waiting, prostate cancer mortality and quality of life. Inclusion started in October 2016 and in October 2018; 275 patients have been enrolled. Ethics and dissemination Ethical approval was obtained in each participating country. Results for the primary and secondary outcome measures will be submitted for publication in peer-reviewed journals. Trial registration number NCT02914873.
|
|
| 2. |
- Lee, S. -K, et al.
(author)
-
Reduction of the barrier height and enhancement of tunneling current of titanium contacts using embedded Au nano-particles on 4H and 6H silicon carbide
- 2002
-
In: Materials Science Forum. - : Trans Tech Publications Inc.. - 0255-5476 .- 1662-9752. ; 389-393:2, s. 937-940
-
Journal article (peer-reviewed)abstract
- We have investigated the electrical characteristics of Ti Schottky contacts with embedded Au nano-particles on various types of epilayers of SiC (4H- and 6H-SiC). From our current-voltage (I-V) and capacitance-voltage (C-V) measurements, we observed that Ti Schottky contacts with embedded Au nano-particles had 0.19 eV (n-4H-SiC) and 0.15 eV (n-6H-SiC) lower barrier height than those of particle free Ti Schottky contacts. In order to understand this reduction of the Schottky barrier height (SBH) for Ti Schottky contacts with embedded Au nano-particles, it has been proposed that SBH lowering is caused by an enhanced electric field due to the small size of the Au nano-particles and the large SBH difference. We have also tested these contacts on highly doped n-and p-type SiC material to study ohmic contacts using linear TLM measurements.
|
|
| 3. |
- Åberg, Maria A I, 1972, et al.
(author)
-
IGF-I has a direct proliferative effect in adult hippocampal progenitor cells.
- 2003
-
In: Molecular and cellular neurosciences. - 1044-7431. ; 24:1, s. 23-40
-
Journal article (peer-reviewed)abstract
- The aim of the present study was to investigate the potential direct effects of insulin-like growth factor-I (IGF-I) on adult rat hippocampal stem/progenitor cells (AHPs). IGF-I-treated cultures showed a dose-dependent increase in thymidine incorporation, total number of cells, and number of cells entering the mitosis phase. Pretreatment with fibroblast growth factor-2 (FGF-2) increased the IGF-I receptor (IGF-IR) expression, and both FGF-2 and IGF-I were required for maximal proliferation. Time-lapse recordings showed that IGF-I at 100 ng/ml decreased differentiation and increased proliferation of single AHPs. Specific inhibition of mitogen-activated protein kinase kinase (MAPKK), phosphatidylinositol 3-kinase (PI3-K), or the downstream effector of the PI3-K pathway, serine/threonine p70 S6 kinase (p70(S6K)), showed that both the MAPK and the PI3-K pathways participate in IGF-I-induced proliferation but that the MAPK activation is obligatory. These results were confirmed with dominant-negative constructs for these pathways. Stimulation of differentiation was found at a low dose (1 ng/ml) of IGF-I, clonal analysis indicating an instructive component of IGF-I signaling.
|
|
| 4. |
|
|
| 5. |
- Åberg, N David, 1970, et al.
(author)
-
Growth hormone increases connexin-43 expression in the cerebral cortex and hypothalamus.
- 2000
-
In: Endocrinology. - 0013-7227. ; 141:10, s. 3879-86
-
Journal article (peer-reviewed)abstract
- Several studies indicate that systemic GH influences various brain functions. Connexin-43 forms gap junctions that mediate intercellular communication and establish the astroglial syncytium. We investigated the effects of peripheral administration of bovine GH (bGH) and recombinant human insulin-like growth factor I (rhIGF-I) on the expression of connexin-43 in the rat brain. Hypophysectomized female Sprague Dawley rats were substituted with cortisol (400 microg/kg x day) and L-T4 (10 microg/kg x day) and treated with either bGH (1 mg/kg x day) or rhIGF-I (0.85 mg/kg x day) for 19 days. The abundance of connexin-43 messenger RNA (mRNA) and protein in the brainstem, cerebral cortex, hippocampus, and hypothalamus was quantified by means of ribonuclease protection assays and Western blots. Treatment with bGH increased the amounts of connexin-43 mRNA and protein in the cerebral cortex and hypothalamus. No changes were found in the brainstem or hippocampus. Infusion of rhIGF-I did not affect connexin-43 mRNA or protein levels in any of the brain regions studied. These results show that administration of bGH increases the abundance of cx43 in specific brain regions, suggesting that GH may influence gap junction formation and thereby intercellular communication in the brain.
|
|
| 6. |
- Åberg, N David, 1970, et al.
(author)
-
Insulin-like growth factor-I increases astrocyte intercellular gap junctional communication and connexin43 expression in vitro.
- 2003
-
In: Journal of neuroscience research. - : Wiley. - 0360-4012. ; 74:1, s. 12-22
-
Journal article (peer-reviewed)abstract
- Connexin43 (cx43) forms gap junctions in astrocytes, and these gap junctions mediate intercellular communication by providing transport of low-molecular-weight metabolites and ions. We have recently shown that systemic growth hormone increases cx43 in the brain. One possibility was that local brain insulin-like growth factor-I (IGF-I) could mediate the effect by acting directly on astrocytes. In the present study, we examined the effects of direct application of recombinant human IGF-I (rhIGF-I) on astrocytes in primary culture concerning cx43 protein expression and gap junctional communication (GJC). After 24 hr of stimulation with rhIGF-I under serum-free conditions, the GJC and cx43 protein were analyzed. Administration of 30 ng/ml rhIGF-I increased the GJC and the abundance of cx43 protein. Cell proliferation of the astrocytes was not significantly increased by rhIGF-I at this concentration. However, a higher concentration of rhIGF-I (150 ng/ml) had no effect on GJC/cx43 but increased cell proliferation. Because of the important modulatory role of IGF binding proteins (IGFBPs) on IGF-I action, we analyzed IGFBPs in conditioned media. In cultures with a low abundance of IGFBPs (especially IGFBP-2), the GJC response to 30 ng/ml rhIGF-I was 81%, compared with the average of 25%. Finally, as a control, insulin was given in equimolar concentrations. However, GJC was not affected, which suggests that rhIGF-I acted via IGF-I receptors. In summary, the data show that rhIGF-I may increase GJC/cx43, whereas a higher concentration of rhIGF-I--at which stimulation of proliferation occurred--did not affect GJC/cx43. Furthermore, IGFBP-2 appeared to modulate the action of rhIGF-I on GJC in astrocytes by a paracrine mechanism.
|
|
| 7. |
|
|
| 8. |
- Back, Pär-Erik, 1961, et al.
(author)
-
Markmiljöns skyddsvärde – En härledning med utgångspunkt i miljöetik och lagstiftning
- 2016
-
Reports (other academic/artistic)abstract
- Vid riskbedömning av förorenade områden ska riskerna som föroreningen utgör bedömas för olika skyddsobjekt, främst människor, markmiljö, grund- och ytvatten. I fördjupade riskbedömningar kan det även vara aktuellt att bestämma lämpliga skyddsnivåer för skyddsobjekten. Till vilken nivå vi väljer att skydda ett objekt beror i hög grad på objektets skyddsvärde. Vad detta skyddsvärde består av och hur stort det anses vara beror i sin tur på vem det är som gör värderingen och vilket miljöetiskt synsätt som tillämpas. När skyddsobjektet markmiljö ska värderas uppstår ofta många frågor och oenigheten mellan olika aktörer kan ibland vara stor.Syftet med publikationen är att tydliggöra vad som avses med begreppet markmiljöns skyddsvärde och beskriva vad det består av. Olika miljöetiska synsätt kan leda till att vår markmiljö värderas olika högt beroende på vem som utför värderingen. I syfte att skapa en gemensam grund för denna typ av värderingar har vi här valt att utgå från den miljöetik som ligger till grund för vår miljölagstiftning. Målet med publikationen är att presentera en härledning av markmiljöns skyddsvärde och ge en grund för hur man kan resonera kring flera av de besvärliga frågor som ställs beträffande skyddet av markmiljön.Rapporten innehåller också en allmän diskussion av skyddsvärdet men beskriver inte konkret hur markmiljön bör värderas vid ett enskilt objekt. Publikationen är med andra ord ingen vägledning i den bemärkelsen att den är direkt tillämpbar för värdering i verkliga projekt. Vår förhoppning är istället att publikationen kommer att utgöra en viktig grund för arbetet med att ta fram framtida vägledningsmaterial för ekologisk riskbedömning samt riskvärdering.
|
|
| 9. |
- Bengtsson, Lars, et al.
(author)
-
Snö och is i vattnets kretslopp
- 1995
-
In: Det evigt vandrande vattnet. - 0348-4394. - 9154603463 ; , s. 33-42
-
Book chapter (other academic/artistic)abstract
- Hur påverkar snön och isen hydrologin i Sverige...
|
|
| 10. |
|
|
